Stokes Capital Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,660
Closed -$491K 87
2022
Q4
$491K Sell
2,660
-325
-11% -$57.1K 0.17% 70
2022
Q3
$496K Buy
2,985
+45
+2% +$9.16K 0.18% 71
2022
Q2
$606K Sell
2,940
-150
-5% -$33.8K 0.21% 67
2022
Q1
$747K Sell
3,090
-40
-1% -$9.27K 0.22% 70
2021
Q4
$762K Hold
3,130
0.23% 64
2021
Q3
$639K Buy
3,130
+30
+1% +$6.42K 0.21% 65
2021
Q2
$640K Sell
3,100
-5,131
-62% -$1.03M 0.21% 65
2021
Q1
$1.57M Buy
8,231
+644
+8% +$119K 0.64% 52
2020
Q4
$1.44M Buy
7,587
+595
+9% +$111K 0.63% 52
2020
Q3
$1.23M Buy
+6,992
New +$1.12M 0.59% 53

Other funds holding STE

Stokes Capital Advisors's STE Position: Q1 2023 in Review

Stokes Capital Advisors sold out of Steris (STE) in Q1 2023, closing a stake of 2,660 shares — an estimated $491K sold.

Stokes Capital Advisors first reported a position in STE in Q3 2020 and held it in 10 quarters. The position peaked at $1.57M in Q1 2021. 621 funds tracked by Wall St. Rank hold STE as of Q1 2023.

  • Stokes Capital Advisors reported no remaining Steris position as of Q1 2023 after selling out during the quarter.
  • Stokes Capital Advisors sold 2,660 Steris shares in Q1 2023, an estimated $491K.
  • Stokes Capital Advisors first reported a position in Steris in Q3 2020 and held it in 10 quarters.
  • Stokes Capital Advisors's Steris position peaked at $1.57M in Q1 2021.
  • 621 funds tracked by Wall St. Rank held Steris as of Q1 2023.

Based on Stokes Capital Advisors's 13F filing for Q1 2023, filed 12 Apr 2023.